Metformin Teva (Metformin)

Metformin reduces hepatic glucose production by inhibiting mitochondrial complex I and activates AMP‑activated protein kinase (AMPK). This dual action decreases gluconeogenesis, increases peripheral insulin sensitivity, and modestly reduces intestinal glucose absorption, collectively contributing to lower blood‑sugar concentrations.

The dose of Metformin Teva is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerance. The prescriber determines the starting dose, titration schedule, and maximum daily amount, ensuring safe and effective therapy.

Metformin may be prescribed during pregnancy or lactation only when the potential benefits outweigh potential risks. Healthcare providers evaluate each case, considering maternal glycaemic control and fetal safety. Breastfeeding mothers should discuss continuation with their clinician, as small amounts of the drug can be excreted in milk.

To place an order, submit an enquiry on the Metformin Teva product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy because it does not cause weight gain and has a low risk of hypoglycaemia when used alone. Compared with sulfonylureas, it has a more favourable safety profile, and unlike insulin, it is administered orally rather than by injection.

Metformin Teva should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid areas such as bathrooms.

Metformin Teva is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets are swallowed whole with a glass of water; they should not be crushed, chewed, or dissolved unless a specific formulation permits it.

The most serious risk is lactic acidosis, a rare but potentially fatal condition characterized by rapid breathing, muscle pain, abdominal discomfort, and feeling of coldness. Patients should seek immediate medical attention if these symptoms develop, especially if they have renal impairment or have consumed excessive alcohol.

Metformin is contraindicated in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, and in patients with severe hepatic disease. It should also be used with caution in the elderly and those with conditions predisposing to hypoxia.